Studies

Golimumab in UC

A Randomized Controlled Trial of Mindfulness-Based Stress Reduction to Prevent Flare-Up in Patients with Inactive Ulcerative Colitis

Infliximab vs adalimumab in postoperative recurrence in CD

New diagnosis pediatric CD different outcomes

Vedolizumab in CD previously expossed to antiTNF

AST-120 (Spherical Carbon Adsorbent) in the Treatment of Perianal Fistulae in Mild-to-Moderate CD

Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial

Infliximab +/- methotrexate in CD

Once versus three times daily dosing of oral budesonide for active Crohn’s disease: A double-blind, double-dummy, randomised trial

Adalimumab +/- ciprofloxacin in perianal CD